Summit Therapeutics PLC

Stock Chart, Company Information, and Scan Results

$24.42(as of Apr 16, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Summit Therapeutics PLC Company Information, Fundamentals, and Technical Indicators

Stock Price$24.42
Ticker SymbolSMMT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees265
CountyUSA
Market Cap$16,375.9M
EBIDTA-1,094.3M
10-Day Moving Average20.15
P/E Ratio-24.49
20-Day Moving Average18.53
Forward P/E Ratio3.72
50-Day Moving Average16.73
Earnings per Share-1.46
200-Day Moving Average19.81
Profit Margin-Infinity%
RSI81.19
Shares Outstanding775.4M
ATR1.20
52-Week High36.91
Volume6,783,429
52-Week Low13.83
Most Recent Support Level18.38
Book Value658.9M
Most Recent Resistance Level20.10
P/B Ratio27.71
Upper Keltner21.22
P/S RatioInfinity
Lower Keltner15.83
Debt-to-Equity Ratio21.22
Next Earnings Date05/07/2026
Cash Surplus152.3M
Next Ex-Dividend DateUnknown

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.

Summit Therapeutics PLC In Our Stock Scanner

As of Apr 17, 2026
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.